Synthetic Biology Market Size Worth USD 78.16 Billion By 2034 | CAGR: 17.2%

The synthetic biology market size is expected to reach USD 78.16 billion by 2034, according to a new study by Polaris Market Research. The report “Synthetic Biology Market Size, Share, Trends, Industry Analysis Report: By Product, By Technology, By Application (Healthcare and Non-Healthcare), and By Region – Market Forecast, 2026–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Synthetic biology is an interdisciplinary field that uses engineering approaches to design, engineer, and modify biological systems for diverse applications, such as healthcare, agriculture, and industrial biotech. The market for synthetic biology is driven by technological advances in genome editing, the rise of sustainable biomanufacturing, and the growing use of synthetic biology in drug discovery, among others.

By product type, oligonucleotide/oligo pools & synthetic DNA segments accounted for the largest market share in the synthetic biology market in 2024, owing to their pivotal role in gene synthesis, genome editing, and molecular diagnostics. The enzymes segment is growing rapidly due to the expanding use of these molecules in DNA synthesis, PCR, and biotechnology.

On a technology basis, the genome editing segment led the synthetic biology market share, mainly because CRISPR-based applications are widely accepted in drug discovery and agriculture. The NGS technology market is currently experiencing rapid growth. This is due to falling costs per sequencing and growing demand for high-throughput genetic analysis.

On the application side, the healthcare industry leads the market share. The segment’s dominance is driven by applications in gene therapy, synthetic vaccines, and precision medicine. The non-healthcare industry is growing significantly with the increasing demand for biodegradable chemicals, engineered plants, and environmental applications related to synthetic biology.

The opportunities presented by bioequivalent substitutes for petrochemicals and food innovation are also contributing to the industry's growth. The major trends that could impact the synthetic biology industry include the incorporation of AI technology to optimize biological processes, biosecurity regulations, and investments and/or collaborations in the industry. The market has the potential to grow as the technology and applications advance.

Several key players are actively contributing to advancements across various sectors. These include Amyris, Inc.; Bruker Cellular Analysis; BICO Group AB; Codexis, Inc.; Ginkgo Bioworks Holdings, Inc.; GenScript Biotech Corporation; Integrated DNA Technologies, Inc.; Insitro, Inc.; Novozymes A/S; Pivot Bio, Inc.; Twist Bioscience Corporation; Viridos, Inc.; and Zymergen Inc. (Acquired by Ginkgo Bioworks Holdings, Inc.

Where is the Market Headed?

Significant R&D investments from the public and private sectors are driving growth in the synthetic biology market. North America leads the market in terms of market share. The regional market is backed by significant investments, research and development, and a mature biotechnology industry. Asia Pacific has significant growth prospects. Infrastructure development and government investments drive the regional market growth.

What Are Synthetic Biology Report Highlights?

• What is the global market size and CAGR for the market during 2026–2034?
• Which factors are contributing to the industry expansion?
• Who are the key industry players? What is their relative position in terms of competitive positioning?
• How do different technologies, such as NGS technology and PCR technology, influence the market landscape?
• How does the market differ in terms of product, technology, application, and geography? Which is the leading application?
• What are the opportunities in different regional markets, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa?
• What are the emerging technologies and innovations in the market?

Request a free sample copy or read the full market insights :  synthetic biology market Report

Polaris Market Research has segmented the synthetic biology market report on the basis of product, technology, application, and region:

By Product Outlook (Revenue – USD Billion, 2021–2034)

• Oligonucleotide/Oligo Pools & Synthetic DNA
• Enzymes
• Cloning Technologies Kits
• Xeno-Nucleic Acids
• Chassis Organism

By Technology Outlook (Revenue – USD Billion, 2021–2034)

• NGS Technology
• PCR Technology
• Genome Editing Technology
• Bioprocessing Technology
• Other Technologies

By Application Outlook (Revenue – USD Billion, 2021–2034)

• Healthcare
• Non-Healthcare

By Regional Outlook (Revenue, USD Billion, 2021–2034)

• North America
  • US
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
• Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America